5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with phosphoramidon in 1 studies
| Studies (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Trials (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Recent Studies (post-2010) (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Studies (phosphoramidon) | Trials (phosphoramidon) | Recent Studies (post-2010) (phosphoramidon) |
|---|---|---|---|---|---|
| 73 | 0 | 8 | 781 | 12 | 33 |
| Protein | Taxonomy | 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide (IC50) | phosphoramidon (IC50) |
|---|---|---|---|
| Thermolysin | Bacillus thermoproteolyticus | 0.033 | |
| Neprilysin | Rattus norvegicus (Norway rat) | 0.0578 | |
| Neprilysin | Oryctolagus cuniculus (rabbit) | 0.0028 | |
| Neprilysin | Homo sapiens (human) | 0.0405 | |
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.615 | |
| Endothelin-converting enzyme 1 | Homo sapiens (human) | 1.0695 | |
| P2Y purinoceptor 12 | Homo sapiens (human) | 0.017 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bird, JE; Durham, SK; Giancarli, MR; Liu, EC; Wasserman, AJ; Webb, ML | 1 |
1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and phosphoramidon
| Article | Year |
|---|---|
Comparison of a novel ETA receptor antagonist and phosphoramidon in renal ischemia.
Topics: Animals; Blood Pressure; Creatinine; Dansyl Compounds; Endothelin Receptor Antagonists; Glomerular Filtration Rate; Glycopeptides; Iodine Radioisotopes; Ischemia; Kidney; Male; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Time Factors | 1995 |